Pathogenesis of sepsis Flashcards
What is sepsis (general)
Sepsis is defined as SIRS in response to an infectious process
Systemic Inflammatory Response Syndrome (SIRS)
Fever - >38 degrees or <36 degrees
Tachypnoea - > 20 rpm or PaCO2 <32mmHG
Tachycardia - >90bpm
Leucocytosis/leucopenia - >12000 ul^-1 or <4000 ul^-1
> or equal to 2 out of 4 required
- Infection (proven or probable)
Problems with SIRS criteria
Too sensitive - may represent a healthy response to infective process
Too non-specific - many SIRS patients have non-infective process
- ‘Infection’ (proven or probable) - too nebulous. Patients with sepsis easily missed
Sepsis 3 criteria
- Organ dysfunction
- Dysregulated host response
- Infection
Immunopathology of sepsis - the endotoxin paradigm
Sepsis begins with wide-spread recognition of generic microbial elements (eg lipopolysaccharide)
- gram negative LPS binding protein (endotoxin)
- CD14
- Toll like receptors (monocyte/macrophage, endothelium) - tLR4
- Receptor associated kinases
- Regulation of cytokine gene transcription
Pathophysiology of sepsis
Pro-inflammatory cytokines
- Increase in vascular permeability
- Decrease in vascular resistance
- Decrease in cardiac contractility
- Fever, diarrhoea
- Metabolic changes (insulin resistance, protein catabolism)
- increase in neutrophil migration, adhesion
- Increase in coagulation
Cardiovascular changes in sepsis
Early distributive shock(warm peipheries) - peripheral vasodilatation
Then hypovolaemic shock(cold peropheries) - capillary leak, peripheral and pulmonary oedema, low filling pressure(fluid responsive)
Late cardiogenic shock(cold peripheries) - cardiac myocyte suppression, high filling pressure (not fluid responsive)
Coagulation response in sepsis
Coagulation homeostasis disrupted early and profoundly in sepsis
- Platelet activation
- Activation of coagulation cascades
- Down-regulation of anticoagulant mediators
- Consumption of coagulation factors
- Coagulation and inflammation closely linked
Coagulation factors –> pro-inflammatory activity
Anticoagulation factors –> anti-inflammatory activity
Coagulopathy in sepsis
Intrinsic ‘contact activation’ pathway
Loss of endothelial integrity –> VIII –> thrombin –> fibrin clot
Extrinsic ‘tissue factor’ pathway
Monocyte –> IL1, TNF-alpha –> TF-VII–. Thrombin –> fibrin clot
What is consumption coagulopathy (disseminated intravascular coagulation)
- Acquired disturbance of blood clotting leading to an increased turnover of coagulation factors and platelets by which the production sites are being exhausted
Metabolic changes in sepsis
- Protein catabolism
- Insulin resistance
- Decrease in tissue oxygen uptake (altered mitochondrial function)
What do circulatory changes, coagulation and metabolic changes in sepsis lead to
Tissue hypoxia –> lactic acidosis
Other examples of PAMPS in sepsis
- Lipopeptides
- Peptidoglycans
- Flagellin
- Microbial DNA/RNA
Other examples of PRRs in sepsis
- TLRs1-11
- CD14
- NOD1 and 2
- Beta integrins
- Mannose binding lectin
Sepsis aetiology
- Constantly changes
- 1980s predominantly gram negative
- 1990s-2000s emergence of gram positives
- 2010s emergence of yeasts, re-emergence of gram negatives - Varies geographically
e. g. case mix - Major changes in paediatrics with vaccination - disappearance of meningococcus, hemophilus, pneumococcus